Company intelligence / Profile preview

Mimosa Acoustics

Champaign, Illinois, United Statesmimosaacoustics.com ↗

Ownership: Private
Employees: ~19
Development stage: Other

Overview

Mimosa Acoustics develops and markets FDA-cleared medical devices for rapid, non-invasive assessment of middle and inner ear health. Their products are used by clinicians and researchers to screen for hearing loss—including in newborns—and to diagnose conditions such as middle-ear effusion. The company’s systems combine patented wideband acoustic immittance analysis with otoacoustic emission testing in a single probe fit. Devices are commercially available since at least October 2006.

Therapeutic areas: NeurologyInfectious Diseases
Modalities: DeviceNon-pharmacological therapy (diagnostic devices for hearing assessment)
Industry: Physiological Monitoring

Partnerships

Collaborates closely with leading academic researchers but no major pharma/biotech partnerships disclosed

Beyond the preview

Go deeper on Mimosa Acoustics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mimosa Acoustics.

Explore the full profile